TRADING UPDATES: EnSilica hails "solid" half-year; Aptamer revenue up
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 0.29p on 09-01-2026 at 19:40:09 |
|---|---|
| Change | -0.003p -1% |
| Buy | 0.30p |
| Sell | 0.28p |
| Last Trade: | Buy 200,000.00 at 0.297p |
| Day's Volume: | 33,464,283 |
| Last Close: | 0.297p |
| Open: | 0.30p |
| ISIN: | GB00BMD1Z199 |
| Day's Range | 0.297p - 0.30p |
| 52wk Range: | 0.1095p - 0.395p |
| Market Capitalisation: | £20.22m |
| VWAP: | 0.292434p |
| Shares in Issue: | 6.81b |
Sector: Medicine and Biotech
Solvonis Therap (SVNS) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 200,000 | 0.297p | Suspected BUY Trade |
16:35:07 - 09-Jan-26 |
| Sell* | 1,000,000 | 0.2871p | Ordinary |
16:27:42 - 09-Jan-26 |
| Sell* | 2,148,013 | 0.2865p | Ordinary |
15:55:47 - 09-Jan-26 |
| Buy* | 17,500 | 0.2974p | Ordinary |
15:55:20 - 09-Jan-26 |
| Sell* | 6,000,000 | 0.29p | Ordinary |
15:29:11 - 09-Jan-26 |
| Buy* | 2,334,499 | 0.2935p | Ordinary |
15:24:03 - 09-Jan-26 |
| Buy* | 1,299,145 | 0.2925p | Ordinary |
14:58:41 - 09-Jan-26 |
| Buy* | 31,993 | 0.2925p | Ordinary |
14:57:38 - 09-Jan-26 |
| Buy* | 1,000,000 | 0.2928p | Ordinary |
14:57:15 - 09-Jan-26 |
| Sell* | 689,654 | 0.29p | Ordinary |
14:50:00 - 09-Jan-26 |
Solvonis Therap (SVNS) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Jan 2026 7:00 am | RNS | US Patent allowance for PTSD discovery programme |
| 22nd Dec 2025 7:00 am | RNS | Research and Development Update - Q4 2025 |
| 22nd Dec 2025 7:00 am | RNS | Research and Development Update – Q4 2025 |
| 3rd Dec 2025 7:00 am | RNS | SVN-015 accepted into US NIDA funded programme |
| 31st Oct 2025 3:59 pm | RNS | Total Voting Rights |
| 31st Oct 2025 7:00 am | RNS | Corporate Structure Update and Issue of Options |
| 27th Oct 2025 7:00 am | RNS | Appoints global biopharma leader Paul Carter |
| 16th Oct 2025 7:00 am | RNS | Raises £1.25 Million to Accelerate Programmes |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |
| 28th Aug 2025 7:00 am | RNS | Solvonis secures exclusive CNS collaboration |